Bison Wealth’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-864
Closed -$210K 205
2017
Q2
$210K Hold
864
0.17% 167
2017
Q1
$206K Buy
+864
New +$201K 0.18% 159
2016
Q4
Sell
-915
Closed -$211K 200
2016
Q3
$211K Sell
915
-30
-3% -$7.33K 0.18% 157
2016
Q2
$218K Sell
945
-99
-9% -$22.8K 0.13% 175
2016
Q1
$280K Sell
1,044
-179
-15% -$51.2K 0.18% 134
2015
Q4
$382K Sell
1,223
-705
-37% -$210K 0.22% 135
2015
Q3
$524K Buy
1,928
+431
+29% +$132K 0.34% 97
2015
Q2
$454K Sell
1,497
-832
-36% -$248K 0.26% 117
2015
Q1
$693K Buy
2,329
+1,038
+80% +$296K 0.42% 77
2014
Q4
$332K Buy
+1,291
New +$323K 0.25% 127

Other funds holding AGN

Bison Wealth's AGN Position: Q3 2017 in Review

Bison Wealth sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 864 shares — an estimated $210K sold.

Bison Wealth first reported a position in AGN in Q4 2014 and held it in 10 quarters. The position peaked at $693K in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Bison Wealth reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Bison Wealth sold 864 Allergan plc shares in Q3 2017, an estimated $210K.
  • Bison Wealth first reported a position in Allergan plc in Q4 2014 and held it in 10 quarters.
  • Bison Wealth's Allergan plc position peaked at $693K in Q1 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Bison Wealth's 13F filing for Q3 2017, filed 27 Oct 2017.